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Practical application of UKCDR Safeguarding Guidance during COVID-19
The world’s attention is focused on the threat and impact of the COVID-19 
pandemic, and researchers are at the forefront of the response. At the same 
time, many institutions have suspended non-COVID-related domestic and 
international research activities, in light of the potential hazards to both 
researchers and participants and the effects of political/social restrictions 
such as lockdowns, curfews and physical distancing.
Safeguarding – the responsibility to anticipate, mitigate and address harm 
– remains an essential function for all those involved in the international 
development research chain, whatever the focus of their research. The UK 
Collaborative on Development Research (UKCDR) define safeguarding in the 
research context as preventing and addressing “any sexual exploitation, 
abuse or harassment of research participants, communities and research 
staff, plus any broader forms of violence, exploitation and abuse… such as 
bullying, psychological abuse and physical violence.” 
Safeguarding in international development research takes on added 
significance during the COVID-19 crisis, for a number of reasons:
 l During emergencies, people and organisations can forget or overlook the 
importance of safeguarding in the face of immediate survival needs. 
 l Many institutions’ normal governance and oversight processes, including 
those for reporting or investigating safeguarding concerns, are delayed 
or severely disrupted; whistle-blowers may be ignored or even suffer 
retaliation.1
Introduction
 l Unscrupulous actors may seize the opportunity to commit abuse or 
perpetrate harm during a time of lowered scrutiny and drastically reduced 
or overburdened public services. For example, emerging evidence from 
the international development sector strongly points to increases in 
domestic violence, sexual exploitation and sexual violence against women 
and girls during the COVID-19 pandemic2,  as well as heightened risk to 
children of neglect, abuse and exploitation.3 
 l While certain safeguarding risks may appear temporarily reduced by 
restrictions on movement, closure of workplaces, etc., harm and abuse will 
manifest themselves in other ways, and specific new risks can arise as a 
result of the pandemic.
 l Researchers may be inclined to undertake more risky actions during 
a widespread crisis, because risks are perceived as being everywhere – 
individuals’ ‘risk line’ or definition of what constitutes acceptable risk can 
shift.
 l Research may have to be undertaken rapidly in emergency situations, 
with pressure to allow perceived urgency to override normal steps to 
anticipate potential harms, take action to mitigate harm and put in place 
or strengthen appropriate processes to address it.
 l Ability to carry out basic institutional functions, including the ongoing 
responsibilities of research funders/institutions to discharge their duty of 
care in relation to their staff, grant-holders and research teams, may be 
compromised, and additional risks overlooked.
Why has this additional guidance been produced and 
who is it for?
Please note that the UKCDR’s main Guidance on Safeguarding in 
International Development Research contains rigorous and comprehensive 
role-specific advice on safeguarding in international development research, 
with clearly targeted sections for research funders, heads of research 
institutions, university vice-chancellors, ethics committees, research 
managers and administrators, human resources, legal and finance teams, 
individual researchers, research participants and communities. 
The purpose of this additional ‘companion piece’ is to underline the 
importance of safeguarding in research in the context of COVID-19, 
highlight specific issues to consider during the current crisis and signpost 
additional useful resources. The core values and ethical principles that 
underpin safeguarding, research integrity and equitable partnerships 
should continue to drive our approach to research during the pandemic:
“It is profoundly unethical for people to be approached to take part in 
research (however potentially valuable) if their own basic healthcare needs 
are not being addressed as part of the response effort. While researchers 
cannot themselves be directly responsible for meeting such needs, they 
must be confident that they know how to refer on to those who are (and that 
those services are in place). Equal respect also reminds us of the importance 
of the welfare of front-line research and healthcare workers themselves, and 
the responsibilities of their employers and funders to make sure that their 
needs are not overlooked.” 4
The considerations below will be most relevant to those funding research, 
those managing research grants and those undertaking research. While this 
companion piece largely targets these three groups, there is greater detail 
in the full guidance for all stakeholder groups involved in research (as listed 
above). This document is a supplement to – not a replacement for – the 
advice in the main Guidance, which remains valid and relevant in the face of 
COVID-19.5
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Rights of victims/survivors and whistle-
blowers Equity and fairness
What additional safeguarding issues do we need to consider in the 
current outbreak?
 l What measures are we taking to identify specific additional 
safeguarding risks in our current (whether active or suspended) 
or planned research in the context of COVID-19, and to ensure 
the resilience and effectiveness of our reporting/investigation/ 
disciplinary procedures?
 l How are we protecting the rights of participants in COVID-specific 
research, e.g. the right to compensation for time/loss of earnings and 
the right to know where and how to access health care? 
 l How are we ensuring meaningful, fully informed and freely given 
consent (especially when under pressure to produce rapid results)? 
Are we avoiding undue inducement in any compensation we offer for 
participation in research? Do our existing consent procedures need 
to be revisited and possibly revised in the context of COVID-19?
 l How are we ensuring support in relation to the anticipated rise in 
mental health issues / intimate partner violence affecting research 
staff and students working from home, in self-isolation, under 
quarantine or lockdown?
 l How are we helping staff and students who are away from home and 
may be finding it difficult to return, to access health care where they 
are working?
 l In countries where authoritarianism is increasing as a result of 
enforcement of COVID-19 requirements, how are we protecting the 
safety of researchers, field workers, data collectors and research 
participants and ensuring they are not being placed at higher risk 
of physical violence? (e.g. if field workers/researchers are expected to 
work late, or research participants are involved in studies until later in 
the day, they may miss curfew and be subject to police brutality)
 l How are we ensuring that all research partners and participants are 
receiving accurate, up-to-date information about COVID-19 relevant to 
their project and country, so that they are not placing themselves or 
others at unnecessary risk when undertaking research?
 l Have we taken into account individuals or groups with particular 
characteristics who risk being affected disproportionately by any 
changes made to research during this period? (e.g. additional costs 
or absence of income arising from pausing/freezing research, which 
may exacerbate their risk or vulnerability to sexual exploitation, abuse, 
harassment, bullying, psychological abuse, physical violence)
 l What support are we offering, particularly for those researchers in 
more precarious employment situations – such as temporary staff, 
sub-contractors, students – and/or with less access to credit or a social 
safety net, who may be more vulnerable to exploitation? (e.g. processing 
payments quickly, extending contracts, extending deadlines for 
research outputs)
 l What support or alternatives are we offering for those researchers 
whose access to workspace, equipment, reliable electricity supply, 
internet, etc. at home may be limited, so that they can continue to work 
but do so safely? 
 l How are we ensuring that myths about transmission and infection 
(e.g. ‘Chinese virus’, Black people/young/poor/street children having 
immunity, etc.) do not influence research decisions or practice?  What 
are we doing to prevent and address increased racial harassment of 
researchers/participants in relation to these myths?
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Transparency Accountability and governance
 l Are we specifically acknowledging, and consulting partners 
about, the actual and potential impact of COVID-19 on existing 
vulnerabilities and risks in the communities where we fund, manage 
or conduct research?
 l What advice and support are we offering on how research can be 
modified to reduce transmission risk and prevent harm to those 
undertaking and involved in research, e.g. shifting from face-to-face 
data collection to remote methods via phone/ Skype/Zoom or online 
survey etc?
 l How are we communicating what research is still continuing, in what 
form and with what potential financial implications (if modified from 
the original research plan) to provide financial transparency and 
avoid financial exploitation?
 l Are we taking into account the different timing, trajectories and 
impacts of COVID-19 in different countries, so that we are not putting 
researchers or participants at risk in terms of unrealistic expectations 
about the resumption of research activities? 
 l How can we ensure that staff and students can still access advice 
and support on safeguarding concerns? Are there clear routes for 
contacting safeguarding focal points or alternative appropriate 
trained contacts if the primary contact is not available?
 l In the countries where we work, how will we identify and manage 
any changes to referral points or support mechanisms as a result of 
COVID-19? With the suspension or closure of many services, if there 
is nowhere to signpost people to, what is our plan for how to support 
victims/survivors?
 l How readily are we facilitating no-cost extensions (or in the case of 
fixed ongoing costs, costed extensions) to research that has been 
disrupted or suspended? 
 l To what extent are we covering unanticipated costs (e.g. cancelled 
flights, or increased food and lodging costs for researchers stranded 
away from home) to prevent the risk of harassment or exploitation? 
What criteria are we using for these decisions, and are they fair and 
transparent?
 l How are we ensuring that processes are/remain in place to deal with 
any safeguarding breaches during the current disruption? 
 l How are we protecting participants’ data, confidentiality etc. if 
data collection methods are being changed and/or researchers are 
working remotely with less secure networks or software?
 l How have we prepared or modified our ethical approval processes for 
assessing proposed research at this time, ensuring that safeguarding 
risks are still adequately considered?
 l What additional resources might be required to manage 
safeguarding risks in the context of COVID-19?
4Safeguarding in International Development Research: Practical Application of Guidance during COVID-19 
CharitySoWhite (2020) ‘Racial injustice 
in the COVID-19 response’, Live 
position paper. Available at: https://
charitysowhite.org/covid19 
Contextual Safeguarding Network 
(March 2020) ‘Safeguarding, 
adolescents and Coronavirus – 
Contextual Safeguarding during 





Gender and COVID-19 Working 
Group. COVID-19 and Gender 




Interagency Standing Committee 
(March 2020) Interim Technical Note: 
Protection from Sexual Exploitation 
and Abuse (PSEA) during COVID-19 







International Centre for Missing 
& Exploited Children (2020) ‘Child 
Protection During COVID-19 Response’. 
Webpage with updates, guidance and 
resources. Available at: https://www.
icmec.org/child-protection-during-
covid-19-response/
Liverpool School of Tropical Medicine 
and ARISE (Accountability in Urban 
Health Hub): Practical advice on 
COVID-19 for people in informal 
settlements. Video dialogue between 
Prof Sally Theobald and Dr Tom 
Wingfield, COVID-19 expert in Liverpool, 
drawing on questions from Slum/
Shack Dwellers International and ARISE 
Hub members. Full film (22 minutes) 
available at http://bit.ly/ARISE-HUB-
COVID-19, or divided into individual 
topics such as below:
 l What is COVID-19? Are there people 
who are more vulnerable? (4:21) 
https://youtu.be/PFMPuc_Ho8Q
 l Prevention measures? Treatment at 
home? Low-cost measures? (8:45) 
https://youtu.be/Hf8SRM7_tRc
 l Reliable sources of information on 
COVID-19? (3:47) https://youtu.be/
c8gFMyeuknU
 l How to maintain good mental 
health in the face of COVID-19? 
(5:34) https://youtu.be/DD8zIduKnn8
LVCT Health in Kenya (ARISE partner). 
Coronavirus – COVID 19: Kenya Sign 
Language. A public information film 
on COVID-19 for the deaf community 
in Kenya; also creating a twitter chat 
to support action and partnership on 
disability.
Mbuagbaw, L (2017) ‘Considerations and 
guidance in designing equity-relevant 
clinical trials’, International Journal 
for Equity in Health, 16:93. Available 
at: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC5460332/
Nature Medicine (2020) ‘Safeguard 
research in the time of COVID-19’, 
Editorial. Available at: https://www.
nature.com/articles/s41591-020-0852-1
New Philanthropy Capital (2020) ‘How 
philanthropists should respond to 
coronavirus: Consequences, crises and 
opportunities for charities’. Available at: 
https://www.thinknpc.org/resource-hub/
coronavirus-guide/
Nuffield Council of Bioethics (2020) 
Rapid policy briefing: Ethical 
considerations in responding to the 




Social Development Direct (2020) GBV 
Case Management and the COVID-19 




also available in Arabic and Spanish at: 
http://www.sddirect.org.uk/our-work/
gbv-in-emergencies-helpdesk/
Social Science in Humanitarian Action 
et al. Key Considerations: COVID-19 
in Informal Urban Settlements 




UK Aid Direct (2020) ‘Impact of 
COVID-19 Pandemic on Violence 
against Women and Girls’, VAWG 




UNICEF (2020) Protection of children 
during the coronavirus disease 





University of Oxford Research Support 
(2020) ‘COVID-19 funding and project 
management guidance: Guidance from 
research funders, Research Services and 
Research Accounts about the impact of 
coronavirus.’ Webpage being regularly 
updated with policies and measures 




WHO Working Group on Ethics & 
COVID-19 (2020) Ethical standards 
for research during public health 
emergencies: Distilling existing 






















Linnea Renton MPH, with Professor Alex Balch and Dr Leona Vaughn – 
University of Liverpool 
About UKCDR Guidance on Safeguarding in 
International Development Research 
This companion piece was commissioned and produced by the UK 
Collaborative on Development Research (UKCDR) to accompany Guidance 
for Safeguarding in International Development Research. 
UK funders of ODA research worked with UKCDR to develop a set of 
principles and best practice guidance on safeguarding to anticipate, mitigate 
and address potential and actual harms in the funding, design, delivery and 
dissemination of research. This guidance is needed to ensure the highest 
safeguarding standards in the context of international development research, 
which presents specific situations in which harms that can occur are different 
to international development more broadly.
The guidance and other safeguarding resources are available here: 
https://www.ukcdr.org.uk/guidance/safeguarding-resources/

